SpyGlass Pharma (SGP) Stock News & Sentiment

13 Followers

Premium

Ratings

SpyGlass Pharma: Differentiated BIM-IOL Platform and Favorable Risk-Reward Support Buy Rating Ahead of 2028 NDA Catalyst

2M ago

SGP

Yi Chen, an analyst from H.C. Wainwright, has initiated a new Buy rating on SpyGlass Pharma (SGP). Yi Chen has given his Buy rating due to a combination of factors, ...Read more

Premium

Ratings

De‑Risking Milestone and Pipeline Catalysts Underpin High‑Risk Buy on SpyGlass Pharma

2M ago

SGP

Premium

Ratings

SpyGlass Pharma: De-risked BIM-IOL Platform Poised to Reshape Glaucoma Treatment and Drive Upside to Conservative Peak Sales Estimates

3M ago

SGP

News Score - Last 7 Days

Very Positive

SGP

Sector Average

Media Buzz

This Week1 articles

Weekly Average0 articles

News Sentiment

This Week100%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is SGP’s Media Buzz Sentiment?

Currently, no data Available

What is SGP’s weekly average amount of articles?

Currently, no data Available

What is SGP’s News Sentiment?

Currently, no data Available

General Stocks that are Trending in the News

Showing the stocks with the most bullish news sentiment over the past week